BRIM Biotechnology Inc (全福生技) is today to debut its shares on the Emerging Stock Board at an initial offering price of NT$35 per share, the company told an investors’ conference yesterday.
The Taipei Exchange’s Emerging Stock Board is a preparatory board for the nation’s two main bourses.
The company would use the funds raised on the market to conduct phase 3 clinical trials of the BRM421 drug for dry eye disease next year and in 2024, if its meeting with the US Food and Drug Administration upon the conclusion of phase 2 trials goes smoothly this year, it said.
Photo courtesy of BRIM Biotechnology Inc
The company aims to expedite human trials by one year if it has sufficient funds, it said.
Previous human trials for BRM421 showed the drug could stimulate self-renewal of gimbal stem cells and conjunctival goblet cells. That could speed up corneal regeneration and improve the quality of tear, the company said.
“Dry eye disease is a common chronic disease, but has complicated causes,” BRIM chairwoman Jang Hai-shan (簡海珊) said.
“There is no effective treatment yet. More than half of the medicines [for dry eye disease] are anti-inflammatory prescription drugs, with the remaining being artificial tears,” she said.
BRIM is optimistic that BRM421 could be approved as a first-line treatment for dry eye disease, because it is innovative and utilizes a peptide-based regeneration medicine that advances the renewal of stem cells, Jang said.
While it takes about three months for those who use Novartis AG’s dry eye treatment Xiidra to experience relief, it takes about two weeks for those who use BRM421, the company said, adding that its drug has milder side effects, as it is based on a natural short-chain peptide.
Its drug should have an advantage over other treatments in the European market, the company said.
BRIM forecasts a compound annual growth rate of 10.6 percent in the number of patients with dry eye disease from 2018 to 2027, and predicts that the number of patients would grow to 11 billion in 2027, from 5.22 billion in 2020, because people use more electronic devices, wear contact lens more often and have more laser eye surgeries, it said.
Semiconductor stocks on Friday took a beating after a grim profit warning from Idaho-based Micron Technology Inc sparked fresh worries about the US’ earnings power as the country is potentially heading for a recession. Despite a broader stock market rally, the Philadelphia Stock Exchange Semiconductor Index dropped 3.8 percent after Micron, the largest maker of memory semiconductors in the US, flagged that demand was cooling for chips used in computers and smartphones. The index — which is home to US chip giants Advanced Micro Devices Inc and Nvidia Corp, as well as Micron — is down 38 percent this year. Historically, semiconductor
WHOLLY OWNED SUBSIDIARY: Costco Wholesale said it expected the purchase of the remaining 45 percent stake to add 1 to 1.5 percent to its earnings per share US-based Costco Wholesale Corp on Thursday said that it had purchased the remaining 45 percent stake in Costco President Taiwan Inc (台灣好市多) for US$1.05 billion, making the local company a fully-owned unit. “We estimate that the purchase would add about 1 to 1.5 percent to [our] earnings per share,” Costco said in a statement. Costco President Taiwan was established as a joint venture with Kaohsiung-based President Group (大統集團), which held a 45 percent stake. Since the first Costco store opened in Kaohsiung in 1997, 14 outlets have been set up in Taiwan, company data showed. PROFITABLE Three Costco stores in Taiwan — in Taipei’s Neihu
SOARING PROFITS: Semiconductors and shipping have knocked automaking and construction out of the 10 highest paying industries, stock exchange data showed Mobile phone chip designer MediaTek Inc (聯發科) posted an average of NT$5.15 million (US$173,249) in annual compensation for non-managerial employees last year, marking the highest among all firms listed on the Taiwan Stock Exchange (TWSE), exchange data showed. That is a 66 percent increase from the company’s average compensation of NT$3.08 million in 2020, as its earnings per share (EPS) expanded from NT$26.01 in 2020 to NT$70.56 last year. That is also three times higher than the average compensation of NT$1.7 million in the nation’s semiconductor industry, the data showed. The increases helped MediaTek advance its ranking from third in 2020, replacing
A giant aviation deal from China on Friday underscored how trade tensions between Washington and Beijing can impact individual companies, with Boeing Co left looking on as rival Airbus SE scooped up orders worth at least US$37 billion. China’s top three airlines ordered almost 300 Airbus jets — one of the European plane maker’s biggest ever single-day deals — in the first major acquisitions since COVID-19 pandemic restrictions isolated the world’s second-largest economy. “It is disappointing that geopolitical differences continue to constrain US aircraft exports,” a Boeing spokesperson said, adding that sales to China historically support tens of thousands of US